OOIR: Observatory of International Research

Papers

(The H4-Index of Trends in Biotechnology is 55. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Unlocking the potential of stem-cell-derived ‘synthetic’ embryo models	260
Advisory Board and Contents	229
(R)evolution-on-a-chip	219
Human Blood–Brain Barrier on a Chip: Featuring Unique Multicellular Cooperation in Pathophysiology	214
Subscription and Copyright information	168
Potency Meets Precision in Nano-optimized Chemotherapeutics	138
Scalable tissue biofabrication via perfusable hollow fiber arrays for cultured meat applications	118
Microalgae: a revolution for salt-affected soil remediation	117
Healing wounds with plasma-activated hydrogel therapy	112
SynMADE: synthetic microbiota across diverse ecosystems	111
Electronic plants: the future of agriculture and urban ecosystems?	110
Smart Nucleic Acids as Future Therapeutics	106
Phytohormones: novel strategy for removing emerging contaminants and recovering resources	106
Manipulating immune activity of macrophages: a materials and mechanics perspective	101
Analyzing and understanding the robustness of bioprocesses	99
Smart materials: rational design in biosystems via artificial intelligence	95
Designing Artificial Cells towards a New Generation of Biosensors	90
The green revolution of food waste upcycling to produce polyhydroxyalkanoates	89
Vibrio natriegens as a host for rapid biotechnology	89
Enzyme discovery and engineering for sustainable plastic recycling	87
Prime editing: advances and therapeutic applications	79
Does RNAi-Based Technology Fit within EU Sustainability Goals?	79
Engineering biology approaches to modulate bacterial biofilms	78
Food Waste: A Promising Source of Sustainable Biohydrogen Fuel	77
Advisory Board and Contents	76

Advisory Board and Contents	74
Subscription and Copyright information	74
Towards biomanufacturing of cultured meat	73
Subscription and Copyright information	73
Mini-bones: miniaturized bone in vitro models	72
Printhead on a chip: empowering droplet-based bioprinting with microfluidics	71
Beyond waste: understanding urine’s potential in precision medicine	70
Translational organoid technology – the convergence of chemical, mechanical, and computational biology	69
Next-generation digital biomarkers: continuous molecular health monitoring using wearable devices	68
The GPS for drug development: navigating with evidence from human populations	67
Engineering the mangrove soil microbiome for selection of polyethylene terephthalate-transforming bacterial consortia	66
Efficient genome-editing tools to engineer the recalcitrant non-model industrial microorganism Zymomonas mobilis	66
Emerging strategies to develop novel genetically encoded biosensors	63
Integrating bicarbonate-based microalgal production with alkaline sewage for ocean negative carbon emissions	63
Ocular RNA nanomedicine: engineered delivery nanoplatforms in treating eye diseases	63
Engineered Living Materials: Taxonomies and Emerging Trends	62
Manufacturing innovation to drive down cell therapy costs	62
Molecular design of microalgae as sustainable cell factories	61
Machine learning in bioprocess development: from promise to practice	61
Multiscale models quantifying yeast physiology: towards a whole-cell model	61
Machine learning to predict de novo protein–protein interactions	61
A high-performance protein preparation approach in a single column-free step	60
Subscription and Copyright information	59
Emerging supramolecular and living materials in oral medicine	58
Spatial omics for accelerating plant research and crop improvement	58
Dynamically regulating metabolic fluxes with synthetic metabolons	57
Sebum analysis as an advantageous source of biomolecular information	56
Dynamic plasmid copy number control for synthetic biology	56
Advisory Board and Contents	55
Improving awareness, understanding, and enforcement of responsibilities and regulations in Blue Biotechnology	55
A new chapter for anti-idiotypes in low molecular weight compound immunoassays	55